ST Pharmaceutical: Net profit of 15.2458 million yuan in 2024, turning losses into profits year-on-year.

GoldenOctober2024

1-01-01 00:00:00

Jin10 data reported on March 31, ST Muyu announced that the operating income for 2024 is 217 million yuan, a rise of 78.44% year-on-year. The net profit attributable to shareholders of the listed company is 15.2458 million yuan, compared to a net loss of 38.2751 million yuan in the same period last year. The company plans to not distribute profits for the 2024 profit distribution plan, and there will be no transfer of capital reserve to increase share capital or other forms of distribution.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Share

Comment

0/400

No comments

Topic
1/3
1CandyDrop Airdrop Event 6.0
79k Popularity
2Join Alpha RION Airdrop to Earn $40
56k Popularity
3White House Crypto Report
72k Popularity
4Fed Holds Rates Decision
10k Popularity
5Growth Points Draw Round 12 Opens
24k Popularity

sitemap